[FULC] YoY Quarter Result on 30-Sep-2019 [#Q2]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
14-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q2]
Profit Trend
QoQ- -25.61%
YoY- -84.97%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 759 1,183 4,935 1,848 0 0 -
PBT -24,017 -23,738 -20,716 -18,962 -16,542 -8,943 21.83%
Tax 409 313 19 0 -457 -138 -
NP -24,017 -24,051 -20,716 -18,962 -16,542 -8,943 21.83%
Tax Rate - - - - - - -
Total Cost 24,776 25,234 25,651 20,810 16,542 8,943 22.59%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -3,164.30 -2,033.05 -419.78 -1,026.08 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.39 -0.52 -0.57 -0.70 -0.93 -0.53 -5.94%
EPS Diluted -0.39 -0.52 -0.57 -0.70 -0.93 -0.53 -5.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.